日本刀角瓢虫形态特征及生物学特性研究

日本刀角瓢虫是粉虱类害虫的重要捕食性天敌之一、本文详细地描述了日本刀角瓢虫的形态特征，并附有各虫态的特征图。且对日本刀角瓢虫的生活习性进行了观察、以烟粉虱卵为食料，日本刀角瓢虫世代发育历期平均为22．56天，成虫平均寿命为9l94天，平均每雌产卵量为564．8粒：以烟粉虱若虫为食料，日本刀角虫世代发育历期平均为21．70天，成虫平均寿命为81．62天，平均每雌产卵量为650．0粒：瓢虫可捕食烟粉虱的卵、若虫、“蛹”、成虫各虫态，是烟粉虱的有效天敌，具有很好的保护利用价值。     

引诱剂在综合防治桔小实蝇作用中的评估

以使用引诱剂为主 ,坚持在杨桃园挂引诱笼 2 - 3年后 ,大量降低田间桔小实蝇BactroceradorsalisHendel雄虫数量和卵的受精率 ,配合其它的综防措施 ,防效逐年提高。三个综防点试验实践表明 :杨桃每果虫口数 ,卵孵化率及受害果率大大降低 ,防效达 92 5%。对桔小实蝇的防治初见成效。     

云南甘蔗害虫天敌及其自然控制作用

本文简述了云南蔗区甘蔗主要害虫天敌资源及其对害虫的自然控制作用。在云南蔗田内 ,控制甘蔗害虫发生的生物因子主要的可分为捕食性和寄生性两大类。合理保护利用天敌 ,充分发挥天敌对害虫的自然调控作用 ,这对保护生态环境 ,维护蔗田生态平衡 ,提高害虫综合治理水平 ,促进蔗糖业可持续发展均具有重要意义。     

BsC3-41杀蚊幼制剂对蚊幼虫毒杀效果研究

通过以BsC3- 41杀蚊幼制剂对 3种蚊幼虫进行生物活性测定和野外灭蚊试验 ,结果表明 :该制剂对致乏库蚊CulexfatigansWiedemann的毒杀效果最好、对中华按蚊AnophelessinensisWiedemann次之、对白纹伊蚊AedesalbopictusSkuse的效果较差 ,2 4小时LC50值分别为 0 2 0 2 5 μg/ml、 2 5 363μg/ml和 5 9 730 2 μg/ml。野外水体灭蚊使用 3ml/m2 的浓度防治淡色库蚊效果可达 98 88%～ 1 0 0 0 0 % ,使用 1 0ml/m2 的浓度防治中华按蚊效果可达96 81 %～ 1 0 0 0 0 % ,使用 2 0 0ml/m2 的浓度防治白纹伊蚊效果达到 90 64%以上。     

噻二唑基-3-哒嗪酮类化合物的合成及生物活性

将取代的二酰基肼环合后,得到中间体2-芳基-5-氯甲基-1,3,4-噻二唑,然后与2-叔丁基-4-氯-5-羟基-3(2H)-哒嗪酮反应,合成了8个未见文献报道的含噻二唑基哒嗪酮类化合物,其化学结构经1H NMR、高分辩质谱和元素分析确认。生物活性测试结果表明,部分化合物对粘虫P.separate W.有较好的抑制生长活性,其中化合物 3b 的EC50值为21 mg/L。     

Effect of YIGU capsule on IGF-I mRNA and protein expression in rat osteoblasts in vitro

AIM: The effects of YIGU capsule on proliferation and IGF-I mRNA protein expressions in osteoblasts were studied. METHODS: (1) Forty 12-month old Sprague-Dawley female rats were divided randomly into four groups (YIGU capsule high dose group, medium dose group and low dose group; saline group), the drug-containing serum and control serum were prepared. (2) The new-born Sprague-Dawley rat osteoblasts were cultured with different YIGU capsule drug-containing serum at different concentrations and different exposure time. MTT method was used to observe proliferation of osteoblasts. (3) RT-PCR method was used to measure the relative IGF-I mRNA levels and ELISA method was used to measure IGF-I secretion at different exposure time. (4) ELISA method was used to measure IGF-I secretion at different exposure time. RESULTS: (1) Proliferation of osteoblasts was more than the control groups after 48, 72 and 96 h, respectively (P<0.01); (2) The relative IGF-I mRNA levels and IGF-I protein expression were higher than those in control group after 48, 72 and 96 h, respectively (P<0.01 or P<0.05). CONCLUSIONS: It was suggested that YIGU capsule drug-containing serum promoted proliferation, IGF-I mRNA and protein expression. These results may be parts of the mechanisms of YIGU capsule to prevent and treat osteoporosis.     

Long-term effects of TCV116 on left ventricular remodeling and heart function after myocardial infarction in rats

AIM: To investigate the effects of long-term TCV116 on left ventricular remodeling and heart function after myocardial infarction. METHODS: Myocardial infarction (MI) was caused by ligation of the left anterior descending coronary artery in rats. One week after the surgical performance, the surviving rats were randomly assigned to the following treatment protocols: (1) MI rats with no therapy; (2) MI rats treated with TCV116 2 mg/kg per day; (3) Sham-operated control; (4) Sham-operated rats, treated with TCV116 2 mg/kg per day. At 22 weeks, cardiac hemodynamic parameters such as MAP, LVSP, dp/dt_max and LVEDP, and histomorphometric parameters such as LVW/BW and LVCA/BW were measured, mRNA of cardiac genes such as βMHC, BNP, TGF-β₁, collagen I and III were quantified, and survival rates were calculated. RESULTS: Compared with sham-operated rats, MI rats without therapy showed significant increases in histomorphometric parameters as well as in mRAN expressions of cardiac genes (P<0.01); While their hemodynamic parameters were significantly impaired (P<0.01), and survival duration shortened (P<0.05). Compared with MI rats without therapy, MI rats treated with TCV116 showed significant attenuation of mRAN expression of cardiac genes (P<0.01); While their hemodynamic parameters were significantly improved (P<0.05 or P＜0.01), and survival duration extended (P<0.05). CONCLUSION: Treatment with long-term angiotensin II type 1 receptor antagonist may improve left ventricular remodeling and cardiac function after MI in rats.     

Differential regulating effect on estrogen receptor α and β expression in female rat hippocampus and cortex regions between different types of estrogen regents

AIM: To study the regulatory effect two different estrogen reagents on expressions of estrogen receptor α and β in female rat hippocampus and cortex regions. METHODS: 12 cycles after ovariectomy, female rats were orally injected with premarin or progynova for 3 cycles before sacrificed. Semiquantitative RT-PCR was used to detect the ERs mRNA expression and SP immunohistochemistry was performed to measure the ERs protein distribution and expression. RESULTS: In premarin group, ER α mRNA levels in both hippocampus and cortex tissues decreased significantly compared with control. ER α protein level in hippocampus was lower than that in the control. However, ER α protein level in cortex had no statistical difference. ER β mRNA in the two regions and ER β protein in cortex had no statistical differences compared with control, while ER β protein level in hippocampus was higher than that in the control. In progynova group, both mRNA and protein levels of ER β increased significantly in the two regions compared with the control, and ER α mRNA level also increased in hippocampus, but ER α mRNA level in cortex and ER α protein levels in the above two regions showed no statistical differences. CONCLUSION: There were differential regulatory effects on ER α and ER β expression in female rat cognitive regions between the two different types of estrogen reagents, which may be one of the mechanisms of varied effects in different estrogen replacement therapy reagents.     

Recent advances in molecular mechanisms of oncosis

Oncosis is another form of cell death, which is different from apoptosis. The review will discuss the recent advances of oncosis on pathological morphology, nuclear biochemical changes and molecular mechanisms.